Indiqube Spaces IPO subscribed 87 pc on day 1 of offer
The initial share sale received bids for 1,50,00,111 shares against 1,71,48,335 shares on offer, according to NSE data.
Retail Individual Investors (RIIs) part got subscribed 3.41 times while non-institutional investors portion received 78 per cent subscription. The quota for Qualified Institutional Buyers (QIBs) received 6 per cent subscription.
IndiQube Spaces on Tuesday said it has raised over Rs 314 crore from anchor investors.
The Rs 700-crore initial public offer (IPO) of the Bengaluru-based firm will conclude on July 25. The price band has been fixed at Rs 225 to Rs 237 per share.
At the upper end of the price band, the company's valuation is nearly Rs 5,000 crore.
The company is raising Rs 650 crore through issuance of fresh issue, and promoters would offload shares worth Rs 50 crore under the Offer for Sale (OFS). WestBridge Capital, a key investor in the firm since 2018, is not divesting any stake in the OFS.
IndiQube Spaces proposes to utilise the fresh capital to the tune of Rs 462.6 crore towards funding capex for setting up new centres, Rs 93 crore for repayment and the rest for general corporate purposes.
The company, which was incorporated in 2015, manages a portfolio of 8.40 million square feet across 115 properties in 15 cities with a total seating capacity of 1,86,719 as of March 2025. This was a growth from 74 centres and 4.94 million sq ft in March 2023.
IndiQube serves 769 clients, out of which 44 per cent are Global Capability Centres. The company follows an enterprise-first strategy, owing to which 63 per cent of its occupied area comes from clients who have leased over 300 seats. Further, 44 per cent of its revenue is generated from multi-centre clients. Its diverse client mix includes Enphase, Myntra, Zerodha, NoBroker, upGrad, Siemens, Juspay, Perfios, Moglix, Ninjacart, Narayana Health and Allegis, to name a few.
ICICI Securities and JM Financial are the book-running lead managers to the issue.
The equity shares are expected to be listed on July 30 on the BSE and NSE. PTI SUM SUM SHW
(This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments
First Published:
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
4 minutes ago
- Mint
Pfizer Q2 Results: Pharma major's sales jump to $14.65 billion; firm raises profit forecast for 2025 over cost cuts
Aug 5 (Reuters) - Pfizer raised its full-year profit forecast on Tuesday after topping Wall Street expectations for second-quarter results as it expects to benefit from its cost-cutting efforts and a weaker dollar. The company said the new forecast absorbs a one-time charge of 20 cents per share related to its licensing deal with China's 3SBio for experimental cancer treatment. Shares of the New York-based company rose 2.8% to $24.19 in premarket trading. The company's shares have lost more than half their value from their pandemic-era highs as the drugmaker deals with waning revenue from COVID products and looming patent expirations for key drugs. In response, the company launched cost-saving measures last year across its manufacturing and research operations. Pfizer said it was on track to deliver $7.2 billion in net savings from the programs by the end of 2027, out of which about $4.5 billion will be delivered by the end of 2025. J.P. Morgan analyst Chris Schott said that the quarterly beat and the forecast raise did not come as a surprise given the company's better-than-expected cost management. "We would not be surprised with additional upside to EPS as the year progresses," Schott said. The drugmaker now expects to earn $2.90 to $3.10 per share on an adjusted basis in 2025, compared with its previous expectations of $2.80 to $3.00 per share. Total quarterly sales topped estimates by $1 billion and came in at $14.65 billion, including a $22 million favorable impact from foreign exchange. Revenue from Pfizer's antiviral treatment, Paxlovid, was $427 million for the quarter, compared with analysts' expectations of $244.4 million. COVID vaccine Comirnaty, which Pfizer makes with German partner BioNTech, brought in sales of $381 million. Analysts were expecting sales of $188 million. On an adjusted basis, Pfizer earned 78 cents per share for the second quarter, compared with analysts' expectations of 58 cents. (Reporting by Bhanvi Satija and Mrinalika Roy in Bengaluru and Michael Erman in New York; Editing by Anil D'Silva)
Time of India
6 minutes ago
- Time of India
Trucking aggregator Blackbuck logs 56% rise in Q1 revenue, net profit up 17%
Trucking aggregator Blackbuck saw a 56% rise in its revenue from operations for the first quarter (Q1) of financial year 2025-26 to Rs 143.6 crore from Rs 92 crore reported a year Bengaluru-based company's net profit rose just 17.5% year-on-year (YoY) to Rs 33.7 crore from Rs 28.67 crore. However, its net profit plunged 88% on a quarterly Q4 of FY2025, Blackbuck reported a net profit of Rs 280 crore on account of a reduction in total expenses as well as a deferred tax credit of Rs 247 the company's revenue increased by 56% YoY, its expenses also rose to Rs 114 crore in Q1 from Rs 92 crore reported a year earlier. For the June quarter, employee benefit expenses fell marginally to Rs 37 crore from Rs 39 crore, while all other expenses platform's average monthly transacting truck operators grew by 13.87% to 783,399.'Q1 and Q2 are typically the seasonal months in terms of the addition of truck operators and the whole movement of trucks,' the company said in an investors' call. 'Most of the growth typically comes from Q3 and Q4 because that's where the whole operating leverage extends not only to the contribution to Ebitda but also to the sales leverage.'Blackbuck's core business offerings include tolling, vehicle tracking, load platform, vehicle financing, and more. 'The core businesses are growing at 40.62%, leveraging the tailwinds of the trucking industry and strong execution excellence,' the company said in the investor the Q4 results announcement, the company informed the stock exchanges that its board of directors approved a proposal to change the company's name from 'Zinka Logistics Solutions Limited' to 'Blackbuck Limited' or any other name that the Union ministry of corporate affairs approves, subject to shareholder which is backed by Accel and Flipkart, was listed on the stock exchanges last November. The shares of Blackbuck's parent company rose 3.03% to close at Rs 484.45 on the BSE on Tuesday.
Time of India
6 minutes ago
- Time of India
Gujarat top exporting state in 2024-25: FIEO
Gujarat retained its position as India's top exporting state in 2024-25, with outbound shipments worth Rs 9.83 lakh crore, constituting 26.6% of the nation's total exports. Despite a slight dip from the previous year, Gujarat's exports significantly surpassed other states, led by Jamnagar's dominance in petroleum and refinery exports. Uttar Pradesh emerged as a key player, contributing Rs 1. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Gujarat retained its position as India's top exporting state in 2024-25, with outbound shipments worth Rs 9.83 lakh crore, accounting for 26.6 per cent of the country's total exports, FIEO said on said despite a marginal dip from the previous year, Gujarat's exports remained significantly ahead of all other states, nearly Rs 4.3 lakh crore more than Maharashtra (Rs 5,57,271 crore), the second-ranked is followed by Tamil Nadu, Karnataka, Uttar Pradesh, Andhra Pradesh and Telangana, according to the analysis of the Federation of Indian Export Organisations (FIEO)."In 2024-25, Gujarat reaffirmed its leadership as India's top exporting state, accounting for Rs 9.83 lakh crore, which is 26.6 per cent of the country's total exports," it added that Gujarat's export dominance continues to be driven by a few high-performing districts, with Jamnagar maintaining a commanding lead at Rs 3.63 lakh crore, largely owing to its petroleum and refinery contributes over one-third of the state's top five export commodities from the state are Petroleum Products, Gems and Jewellery, Organic Chemicals, Pharmaceuticals, and Engineering Goods (Machinery).In 2024-25, Uttar Pradesh contributes Rs 1.86 lakh crore to India's total exports of Rs 37.02 lakh accounts for 5 per cent of the country's total exports, positioning Uttar Pradesh as an important player in India's export landscape."Uttar Pradesh has demonstrated a commendable diversification in its export markets, reaching both traditional and emerging economies across continents," it said, adding that the US continues to be the top export destination of the state.
